As an example, a meta-analysis by Li et al. of > 2,000 NSCLC patients receiving anti-PD-(L)1 showed that a high pretreatment NLR was associated with inferior PFS (p < 0.001) and OS (p < 0.001) [87]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.